IMiDs: A novel class of immunomodulators

被引：88

作者：

Knight, R ^{[1
]}

机构：

[1] Celgene Corp, Clin Res & Dev Oncol, Summit, NJ 07901 USA

来源：

SEMINARS IN ONCOLOGY | 2005年 / 32卷 / 04期

关键词：

D O I：

10.1053/j.seminoncol.2005.06.018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S24 / S30

页数：7

共 31 条

[1] Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents [J].

Bartlett, JB ;

Dredge, K ;

Dalgleish, AG .

NATURE REVIEWS CANCER, 2004, 4 (04) :314-322

[2] Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes [J].

Bellamy, WT ;

Richter, L ;

Sirjani, D ;

Roxas, C ;

Glinsmann-Gibson, B ;

Frutiger, Y ;

Grogan, TM ;

List, AF .

BLOOD, 2001, 97 (05) :1427-1434

[3]

Corral LG, 1999, J IMMUNOL, V163, P380

[4] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[5] Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects [J].

Dredge, K ;

Marriott, JB ;

Macdonald, CD ;

Man, HW ;

Chen, R ;

Muller, GW ;

Stirling, D ;

Dalgleish, AG .

BRITISH JOURNAL OF CANCER, 2002, 87 (10) :1166-1172

[6]

Gandhi AK, 2004, J CLIN ONCOL, V22, p587S

[7] Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications [J].

Gupta, D ;

Treon, SP ;

Shima, Y ;

Hideshima, T ;

Podar, K ;

Tai, YT ;

Lin, B ;

Lentzsch, S ;

Davies, FE ;

Chauhan, D ;

Schlossman, RL ;

Richardson, P ;

Ralph, P ;

Wu, L ;

Payvandi, F ;

Muller, G ;

Stirling, DI ;

Anderson, KC .

LEUKEMIA, 2001, 15 (12) :1950-1961

[8] Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset [J].

Haslett, PAJ ;

Corral, LG ;

Albert, M ;

Kaplan, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) :1885-1892

[9] Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy [J].

Hideshima, T ;

Chauhan, D ;

Shima, Y ;

Raje, N ;

Davies, FE ;

Tai, YT ;

Treon, SP ;

Lin, B ;

Schlossman, RL ;

Richardson, P ;

Muller, G ;

Stirling, DI ;

Anderson, KC .

BLOOD, 2000, 96 (09) :2943-2950

[10] Immunomodulatory drug costimulates T cells via the B7-CD28 pathway [J].

LeBlanc, R ;

Hideshima, T ;

Catley, LP ;

Shringarpure, R ;

Burger, R ;

Mitsiades, N ;

Mitsiades, C ;

Cheema, P ;

Chauhan, D ;

Richardson, PG ;

Anderson, KC ;

Munshi, NC .

BLOOD, 2004, 103 (05) :1787-1790

← 1 2 3 4 →